A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea

NCT00466635 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Enterocolitis, Pseudomembranous
Diarrhea
Clostridium Difficile

Interventions

DRUG: GT267-004 (tolevamer potassium sodium)

Sponsor

Genzyme, a Sanofi Company